ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.9798
0.04%
Brent Oil
83.785
0.19%
Bitcoin
60,000.00
1.49%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Mereo BioPharma Group PLC (MREO)

  7. Mereo BioPharma Group PLC (MREO) Noticias

MREO Mereo BioPharma Group PLC

3.11
-0.04 (-1.27%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Mereo BioPharma Group PLC MREO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.04 -1.27% 3.11 16:29:41
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.18 3.11 3.24 3.11 3.15
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/4/202406:30GLOBEMereo BioPharma to Participate in Fireside Chat at the 23rd..
27/3/202415:01GLOBEMereo BioPharma Reports Full Year 2023 Financial Results and..
05/3/202406:30GLOBEMereo BioPharma to Participate in Fireside Chat at the..
09/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202415:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202406:08EDGAR2Form 8-K - Current report
08/1/202406:00GLOBEMereo BioPharma Provides Update on Pipeline Progress and..
02/1/202415:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202415:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202415:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202415:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202415:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202415:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202415:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/12/202315:16EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
18/12/202315:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202315:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/10/202315:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/10/202315:01GLOBEMereo BioPharma Reports on Recent Program Developments and..
17/10/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/10/202315:30GLOBEUltragenyx and Mereo BioPharma Announce Interim Phase 2 Data..
09/10/202307:00GLOBEUltragenyx to Present Setrusumab (UX143) Update at ASBMR..
21/9/202306:00GLOBEMereo BioPharma to Participate in Fireside Chat at the 2023..
20/9/202315:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/9/202306:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/9/202306:30GLOBEMereo BioPharma Reports Interim Financial Results for the..
26/7/202315:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/7/202307:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/7/202307:00GLOBEUltragenyx Announces First Patients Dosed in Phase 3 Program..
30/6/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202306:00GLOBEMereo BioPharma to Present at the Jefferies Healthcare..
23/5/202312:43GLOBEPhase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s..
08/5/202311:46GLOBEMereo BioPharma Regains Compliance with Nasdaq Minimum Bid..
05/5/202315:06GLOBEMereo BioPharma Announces Listing Transfer to Nasdaq Capital..

Su Consulta Reciente

NASDAQ
MREO
Mereo BioPharma
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados